Skip to content

Mindfulness-based relapse prevention for substance use disorders: a pilot efficacy trial.

Substance Abuse October 1, 2009 DOI: 10.1080/08897070903250084 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Pilot randomized controlled trial Peer reviewed
Population Adults with substance use disorders
Intervention Mindfulness-based relapse prevention
Topics Addiction Meditation
Key findings Both MBRP and RP groups reduced substance use and increased abstinence, with no significant differences between groups on most outcomes, suggesting MBRP is feasible and may be comparable to RP, but efficacy requires further study.

Abstract

Mindfulness-based relapse prevention for substance use disorders: a pilot efficacy trial.

Comparable studies

Other randomized controlled trials on addiction, most cited first.

Study Year Design Participants
Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder Adults aged 25–65 with DSM-IV alcohol dependence and at least 4 heavy drinking days in... 2022 Randomized controlled trial n = 95
Ketamine psychotherapy for heroin addiction: immediate effects and two-year follow-up. Detoxified heroin-addicted patients 2002 Randomized controlled trial n = 70
A Single Ketamine Infusion Combined With Motivational Enhancement Therapy for Alcohol Use Disorder: A Randomized Midazolam-Controlled Pilot Trial. Adults with alcohol dependence engaged in motivational enhancement therapy 2019 Randomized controlled trial n = 40
A Single Ketamine Infusion Combined With Mindfulness-Based Behavioral Modification to Treat Cocaine Dependence: A Randomized Clinical Trial. Cocaine-dependent adults 2019 Randomized controlled trial n = 55
Single Versus Repeated Sessions of Ketamine-Assisted Psychotherapy for People with Heroin Dependence Detoxified inpatients with heroin dependence 2007 Randomized controlled trial n = 59

Citations in the library

Explore topics